ASX:NTI Neurotech International (NTI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Neurotech International Stock (ASX:NTI) 30 days 90 days 365 days Advanced Chart Get NTI alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket Capitalization$45.85 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNeurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its products includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. Neurotech International Limited was incorporated in 2016 and is based in Nedlands, Australia.Read More… Receive NTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neurotech International and its competitors with MarketBeat's FREE daily newsletter. Email Address NTI Stock News HeadlinesRare opportunities – ASX health stocks tackling unmet medical needsFebruary 13, 2025 | msn.comIs There Now An Opportunity In Neurotech International Limited (ASX:NTI)?December 6, 2024 | finance.yahoo.comYour trading day could end at 11 AMWhat do you usually do between 9:35 AM and 11:00 AM? Catch up on emails? Attend a meeting? Maybe grab a coffee? For me, it's become the most important part of my trading day. 85 minutes. That's usually all it takes. Set up at 9:35 AM… Check back at 11:00 AM. And when things work out, there's an extra $100 to $150 in my account… on a $1000 starting stake. Sounds too simple, doesn't it?February 21, 2025 | ProsperityPub (Ad)Neurotech Director Increases Shareholding in CompanyDecember 6, 2024 | markets.businessinsider.comNeurotech International’s AGM Success and Trial ProgressNovember 20, 2024 | markets.businessinsider.comNeurotech’s NTI164 Shows Promise in Neurological TreatmentNovember 12, 2024 | markets.businessinsider.comDr Anthony Filippis to helm Neurotech as it advances its NTI164 strategy in 2025November 11, 2024 | msn.comNeurotech International Appoints New CEO to Drive GrowthNovember 10, 2024 | markets.businessinsider.comSee More Headlines NTI Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Neurotech International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Neurotech International investors own include Standard Chartered (SCBFY), Advocate Rising Rate Hedge ETF (RRH), Defiance Next Gen H2 ETF (HDRO) and Cleveland-Cliffs (CLF). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryPetroleum And Natural Gas Current SymbolASX:NTI CUSIPN/A CIKN/A Webwww.neurotechinternational.com Phone61 8 9389 3130FaxN/AEmployees7,134Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,070,000.00 Net Margins15,972.18% Pretax MarginN/A Return on Equity-60.73% Return on Assets-37.29% Debt Debt-to-Equity RatioN/A Current Ratio38.81 Quick Ratio3.36 Sales & Book Value Annual Sales$3.18 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares1,030,000,000Free FloatN/AMarket Cap$45.85 million OptionableNot Optionable Beta1.46 10 Best Stocks to Own in 2025Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio. Get This Free Report This page (ASX:NTI) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurotech International Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurotech International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.